VETERINARIA
Departamento
Hospital Infanta Leonor
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Infanta Leonor (9)
2024
2023
-
AB1352 Impact of Systemic Therapies on the Seroprevalence of Sars-Cov-2 in Patients with Immune-Mediated Diseases
Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 1907.1-1907
-
Seroprevalence of SARS-CoV-2 antibodies in patients with immune-mediated inflammatory diseases treated with biological and synthetic targeted therapies
Revista Chilena de Infectologia, Vol. 40, Núm. 6, pp. 618-625
2022
-
Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 59
-
Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs-Findings From the BIOCOVID Study
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, Vol. 28, Núm. 2, pp. e348-e352
-
Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs—Findings From the BIOCOVID Study
JCR: Journal of Clinical Rheumatology, Vol. 28, Núm. 2, pp. e348-e352
2020
-
Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study
Clinical Rheumatology, Vol. 39, Núm. 9, pp. 2751-2756
-
Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study
CNS Drugs, Vol. 34, Núm. 12, pp. 1275-1286
-
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population
Journal of Neurology, Vol. 267, Núm. 8, pp. 2362-2371